Presentation is loading. Please wait.

Presentation is loading. Please wait.

Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States  Sudhir K. Unni, PhD, MBA, Ruben G.W.

Published byThomasina Hart Modified over 5 years ago

Similar presentations

Presentation on theme: "Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States  Sudhir K. Unni, PhD, MBA, Ruben G.W."— Presentation transcript:

1 Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States  Sudhir K. Unni, PhD, MBA, Ruben G.W. Quek, PhD, Joseph Biskupiak, PhD, MBA, Vinson C. Lee, PharmD, MS, FCPhA, Xiangyang Ye, MS, Shravanthi R. Gandra, PhD, MBA  Journal of Clinical Lipidology  Volume 10, Issue 1, Pages e3 (January 2016) DOI: /j.jacl Copyright © 2016 National Lipid Association Terms and Conditions

2 Figure 1 Patient selection flowchart. CHD, coronary heart disease; CHD RE, coronary heart disease risk equivalent; CKD, chronic kidney disease; CV, cardiovascular. Journal of Clinical Lipidology  , e3DOI: ( /j.jacl ) Copyright © 2016 National Lipid Association Terms and Conditions

3 Figure 2 Statin therapy patterns. CHD, coronary heart disease; CHD RE, coronary heart disease risk equivalent; CV, cardiovascular. Journal of Clinical Lipidology  , e3DOI: ( /j.jacl ) Copyright © 2016 National Lipid Association Terms and Conditions

4 Figure 3 Proportion of patients with low-density lipoprotein cholesterol ≥ 100 mg/dL pre- and post-index date in the 3 cohorts. CHD, coronary heart disease; CHD RE, coronary heart disease risk equivalent; CV, cardiovascular; LDL-C, low-density lipoprotein cholesterol. Journal of Clinical Lipidology  , e3DOI: ( /j.jacl ) Copyright © 2016 National Lipid Association Terms and Conditions

5 Figure 4 Cumulative incidence rate of post-index CV events for CHD and CHD RE cohorts. CABG, coronary artery bypass graft; CHD, coronary heart disease; CHD RE, coronary heart disease risk equivalent; CV, cardiovascular; PCI, percutaneous coronary intervention. Journal of Clinical Lipidology  , e3DOI: ( /j.jacl ) Copyright © 2016 National Lipid Association Terms and Conditions

Download ppt "Assessment of statin therapy, LDL-C levels, and cardiovascular events among high-risk patients in the United States  Sudhir K. Unni, PhD, MBA, Ruben G.W."

Similar presentations

The “occasional open heart surgeon” revisited

The “occasional open heart surgeon” revisited
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality  Rishi K. Wadhera,

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality  Rishi K. Wadhera,
Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,

Lipid abnormalities in foreign-born and US-born patients in a medical group  Jawali Jaranilla, MD, MPH, Terese DeFor, MS, Gabriela Vazquez Benitez, PhD,
Copyright © 2012 American Medical Association. All rights reserved.

Copyright © 2012 American Medical Association. All rights reserved.
Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.

Acute Kidney Injury and In-Hospital Mortality after Coronary Artery Bypass Graft versus Percutaneous Coronary Intervention: A Nationwide Study Shen et.
2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?  Sripal Bangalore, MD,

2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?  Sripal Bangalore, MD,
Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.

Erythrocyte long-chain omega-3 fatty acid levels are inversely associated with mortality and with incident cardiovascular disease: The Framingham Heart.
Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016  Angela C. Webster, PhD, Evi V. Nagler, MD,

Development of Clinical Practice Guidelines in the Care of People With Kidney Disease: Core Curriculum 2016  Angela C. Webster, PhD, Evi V. Nagler, MD,
Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A

Cyrus J. Parsa, MD, Linda K. Shaw, MS, J. Scott Rankin, MD, Mani A
Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results.

Corn oil improves the plasma lipoprotein lipid profile compared with extra-virgin olive oil consumption in men and women with elevated cholesterol: Results.
Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial.

Efficacy and safety of the proprotein convertase subtilisin/kexin type 9 monoclonal antibody alirocumab vs placebo in patients with heterozygous familial.
An assessment by the Statin Liver Safety Task Force: 2014 update

An assessment by the Statin Liver Safety Task Force: 2014 update
Chapter 2: Pharmacological cholesterol-lowering treatment in adults

Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F

Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F
The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting  Danny Chu, MD, Faisal.

The impact of placing multiple grafts to each myocardial territory on long-term survival after coronary artery bypass grafting  Danny Chu, MD, Faisal.
Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients  Evan Stein, MD, Harold Bays, MD, Michael Koren,

Efficacy and safety of gemcabene as add-on to stable statin therapy in hypercholesterolemic patients  Evan Stein, MD, Harold Bays, MD, Michael Koren,
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia  Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,

Emerging LDL therapies: Mipomersen—antisense oligonucleotide therapy in the management of hypercholesterolemia  Peter P. Toth, MD, PhD, FAAFP, FICA, FNLA,
Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with.

Glucagon-like peptide-1 receptor agonists reduced the low-density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus treated with.
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality  Rishi K. Wadhera,

A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality  Rishi K. Wadhera,

Similar presentations

Ads by Google